Celestone cronodose (Bethametasone)

Phase 3Small molecule

FFundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias

Celestone cronodose (Bethametasone) is one of 23 small molecule programs targeting Tendinopathy. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

TendinopathyActive, not recruiting

TendinopathyPhase 3

Active, not recruiting

Competition

Competitive Landscape

49 competitors in Tendinopathy

#DrugCompanyPhaseTrials

Arcoxia

Novartis

Approved

1 2

Voltaren

Novartis

Approved

1 3

Cosentyx

Novartis

Phase 3

4 4

Aspercreme Warming

AAveritas Pharma, Inc.

Approved

—5

Kenalog

BBausch Health Americas, Inc.

Phase 3

1 6

Restasis

TTaiwan Bio Therapeutics Inc.

Whole Blood

1 8

Ketalar

HHelse Møre og Romsdal HF

Phase 3

1 9

Xylocaine

MMEDRx USA, Inc.

Phase 2

1 10

Genotropin

EMD Serono

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Tendinopathy1 trial

Effect of Plasma Rich in Growth Factors in Rotator Cuff Tendinopathy

Completed·FFundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias·Phase 3·NCT01915979·84 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Celestone cronodose (Bethametasone). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Celestone cronodose (Bethametasone) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Celestone cronodose (Bethametasone). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Fundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: FFundacion para la Investigacion Biomedica del Hospital Universitario Principe de Asturias

Celestone cronodose (Bethametasone)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Tendinopathy1 trial

References

Drug Info

Quick Facts

Related News